Showing results (311-320 of 381) with videos related to
Sort By:
Pageof 39
Vaccines|September 28, 2024
Nonreciprocity in CHIKV and MAYV Vaccine-Elicited ProtectionWhitney C Weber, Takeshi F Andoh, Craig N Kreklywich, et al.Molecular Pharmacology|December 2, 2010
A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levelsMargaret A Park, Hossein A Hamed, Clint Mitchell, et al.Cancer Research|March 13, 2002
Treatment of ovarian cancer with a tropism modified oncolytic adenovirusGerd J Bauerschmitz, John T Lam, Anna Kanerva, et al.The Journal of Gene Medicine|October 20, 2004
Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapyJohn T Lam, Anna Kanerva, Gerd J Bauerschmitz, et al.Blood|July 16, 2008
A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migrationRieneke van de Ven, George L Scheffer, Anneke W Reurs, et al.International Journal of Molecular Sciences|June 28, 2023
In Vitro and In Vivo Efficacy of a Stroma-Targeted, Tumor Microenvironment Responsive Oncolytic Adenovirus in Different Preclinical Models of CancerAna Alfano, Eduardo G A Cafferata, Mariela Gangemi, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2003
Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirusAnna Kanerva, Kurt R Zinn, Tandra R Chaudhuri, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2009
Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approachAdelaide Greco, Altomare Di Benedetto, Candace M Howard, et al.Breast Cancer Research : BCR|February 7, 2006
Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model systemMariam A Stoff-Khalili, Alexander Stoff, Angel A Rivera, et al.Human Gene Therapy|June 11, 2015
A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental GliomaJulius W Kim, J Robert Kane, Jacob S Young, et al.Pageof 39